Cannabics Pharmaceuticals appoints Gabriel Yariv as Executive Chairman

CNBX Pharmaceuticals Inc.

Gabriel Yariv appointed as Executive Chairman effective September 3, 2021.
Yariv brings over 20 years experience in medical industry; co-founded BreathID (now Medtronic) and SimuTec.
Yariv will continue as Director and Chief Operational Executive while serving as Executive Chair.
Appointment made by unanimous board resolution on September 3, 2021.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Gabriel Yariv

Executive Chairman

CNBX · CNBX Pharmaceuticals Inc.

Effective: 2021-09-05
Filed: September 13, 2021, 7:59 PM ET

On September 5 rd , 2021, the Board of Directors nominated fellow Director Mr. Gabriel Yariv as Executive Chairman of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gabriel Yariv was appointed as Executive Chairman at CNBX Pharmaceuticals Inc..

Action: nominated
Role: Executive Chairman

Exact text from the filing

On September 5 rd , 2021, the Board of Directors nominated fellow Director Mr. Gabriel Yariv as Executive Chairman of the Board.

View on SEC.gov

CNBX Pharmaceuticals Inc. filing history →

Source: SEC EDGAR

accession 0001683168-21-004239

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.